References
- Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411–423.
- Hou X, Parkington HC, Coleman HA, Mechler A, Martin LL, Aguilar MI, Small DH. Transthyretin oligomers induce calcium influx via voltage-gated calcium channels. J Neurochem 2007;100:446–457.
- Kagan BL, Azimov R, Azimova R. Amyloid peptide channels. J Membr Biol 2004;202:1–10.
- Mirzabekov TA, Silberstein AY, Kagan BL. Use of planar lipid bilayer membranes for rapid screening of membrane active compounds. Methods in Enzymology 1999;294:661–674.
- Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr Pharm Des 2008;14:3219–3230.
- Jang H, Arce FT, Ramachandran S, Capone R, Azimova R, Kagan BL, Nussinov R, Lal R. Truncated beta-amyloid peptide channels provide an alternative mechanism for Alzheimer's disease and Down syndrome. Proc Natl Acad Sci USA 2010;107:6538–6543.